Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Lenalidomide 10 mg Capsule
Therapeutic Category
Oncology, Anticancer
Dosage Form
Capsule
Packaging Type
in a Bottle
Packaging
30 Capsules
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
LENABOT 10 Capsules (Lenalidomide 10 mg) is a cornerstone oral medication in hematological oncology, classified as an Immunomodulatory Drug (IMiD). It is primarily used for the management of Multiple Myeloma (MM), a complex, chronic blood cancer.
Mechanism and Impact:Lenalidomide has a three-pronged effect:
Immunomodulation: It enhances the body's natural killer (NK) and T-cell anti-tumor responses.
Anti-Angiogenesis: It prevents the formation of new blood vessels needed by the tumor.
Direct Anti-Proliferation: It inhibits the growth and survival of myeloma cells.This powerful combination makes it essential for achieving deep, durable responses in MM patients, often in combination with Dexamethasone.
Key Therapeutic Uses:
Multiple Myeloma: Used in newly diagnosed and relapsed/refractory patients, as well as for long-term maintenance therapy.
Myelodysplastic Syndromes (MDS): Specifically for transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality.
Due to the chronic nature of MM and the critical safety protocols required for dispensing (e.g., REMS programs), Lenalidomide 10 mg represents a high-barrier, high-trust, and remarkably stable market segment. We offer an exclusive PCD Pharma Franchise opportunity for LENABOT 10, securing a dominant position in the high-value hematological oncology sector.
Common side effects include nausea, dizziness, stomach discomfort, muscle pain, headache, and an increased risk of bleeding or bruising.
Rosutyle Gold 20/150 Tablet is prescribed for individuals at high risk of cardiovascular diseases, including heart attack, stroke, and atherosclerosis, especially those with high cholesterol and hypertension.
Use only under medical supervision. Regular monitoring of cholesterol levels, liver function, and bleeding risk is recommended.
Store at room temperature (15-30°C) in a dry place away from direct sunlight and moisture. Keep out of reach of children.
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Rosuvastatin 20mg + Clopidogrel 75mg Tablet
Composition : Prazosin (2.5mg) Sustained Release Tablet
Composition : Prazosin (5 mg) Sustained Release
Composition : Metoprolol Succinate 100mg PR Tablet
Composition : Metoprolol 12.5 XL Tablet
Composition : Metoprolol Succinate (25mg) ER Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Lenalidomide 10mg Capsule is a specialty oncology medicine used in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain blood cancers, making it a high-value oncology and hematology segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from demand in oncology centers, cancer hospitals, hematology clinics, and specialty care institutions. As a critical therapy for long-term cancer management, it contributes to a strong specialty-care portfolio.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for oncology and specialty-care formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from specialty prescription demand, institutional procurement opportunities, and long-term treatment requirements associated with oncology and hematology care when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this oncology formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.